Advanced search
Publication Cover
Infectious Diseases Volume 56, 2024 - Issue 5
Submit an article Journal homepage
73
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Empiric treatment of healthcare-associated central nervous system infections in Denmark: do we need carbapenems?

Christian Kraefa Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Kobenhavn, DenmarkCorrespondence[email protected]
,
Frederik Boetius Hertzb Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Kobenhavn, Denmark;c Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
,
Birthe Riis Olesend Hospital Administration/Pharmacy, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
,
Sigurdur Thor Sigurdssone Department of Neuroanesthesiology, Copenhagen University Hospital - Rigshospitalet, Kobenhavn, Denmark
,
Ove Ketil Bergdalf Department of Neurosurgery, Copenhagen University Hospital – Rigshospitalet, Kobenhavn, Denmark
,
Jon Gitz Hollerg Department of Infectious Diseases, Copenhagen University Hospital - North Zealand, Kobenhavn, Denmark
,
Helene Mensa Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Kobenhavn, Denmark
,
Jannik Helweg-Larsena Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Kobenhavn, Denmark
,
Åse Bengaard Andersena Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Kobenhavn, Denmark
,
Kirsten Møllere Department of Neuroanesthesiology, Copenhagen University Hospital - Rigshospitalet, Kobenhavn, Denmark
&
Jenny Dahl Knudsenb Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Kobenhavn, Denmark
 show all
Pages 402-409 | Received 22 Dec 2023, Accepted 02 Feb 2024, Published online: 10 Feb 2024

References

  • Sellner J, Täuber MG, Leib SL. Chapter 1 - Pathogenesis and pathophysiology of bacterial CNS infections. In: Handbook of clinical neurology [Internet]. Elsevier; 2010 [cited 2023 Sep 15]. p. 1–16. (Bacterial Infections of the Central Nervous System; vol. 96). Available from: https://www.sciencedirect.com/science/article/pii/S0072975209960018.
  • Ippolito M, Giarratano A, Cortegiani A. Healthcare-associated Central nervous system infections. Curr Opin Anaesthesiol. 2022;35(5):549–554. doi:10.1097/ACO.0000000000001167.
  • Erdem H, Inan A, Guven E, et al. The burden and epidemiology of community-acquired Central nervous system infections: a multinational study. Eur J Clin Microbiol Infect Dis. 2017;36(9):1595–1611. doi:10.1007/s10096-017-2973-0.
  • Corsini Campioli C, Castillo Almeida NE, O’Horo JC, et al. Diagnosis, management, and outcomes of brain abscess due to gram-negative versus gram-positive bacteria. Int J Infect Dis. 2022;115:189–194. doi:10.1016/j.ijid.2021.12.322.
  • Morris A, Low DE. Nosocomial bacterial meningitis, including Central nervous system shunt infections. Infect Dis Clin North Am. 1999;13(3):735–750. doi:10.1016/s0891-5520(05)70103-3.
  • Vårdprogram Bakteriella CNS-infektioner. Avser vuxna patienter med akut bakteriell meningit, neurokirurgisk infektion, tuberkulös meningit, hjärnabscess och neuroborrelios. Svenska Infektionsläkarföreningen; 2020.
  • Healthcare-Associated Ventriculitis and Meningitis. [Internet]. [cited 2023 Sep 15]. Available from: https://www.idsociety.org/practice-guideline/healthcare-associated-ventriculitis-and-meningitis/.
  • Rhoney DH, Tam VH, Parker D, et al. Disposition of cefepime in the central nervous system of patients with external ventricular drains. Pharmacotherapy. 2003;23(3):310–314. doi:10.1592/phco.23.3.310.32108.
  • Lacroix C, Kheloufi F, Montastruc F, et al. Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the french pharmacovigilance database. J Neurol Sci. 2019;398:196–201. doi:10.1016/j.jns.2019.01.018.
  • Beek D van De, Cabellos C, Dzupova O, Esposito S, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22:S37–S62. doi:10.1016/j.cmi.2016.01.007.
  • Viladrich PF, Cabellos C, Pallares R, et al. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1996;40(1):218–220. doi:10.1128/AAC.40.1.218.
  • Wendt S, Ranft D, Rodloff AC, et al. Switching from ceftriaxone to cefotaxime significantly contributes to reducing the burden of Clostridioides difficile infections. Open Forum Infect Dis. 2020;7(9):ofaa312. doi:10.1093/ofid/ofaa312.
  • Antimicrobial resistance surveillance in Europe 2023 - 2021 data [Internet]. 2023 [cited 2023 Nov 22]. Available from: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2023-2021-data.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.